Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hirsch

Showing results (341-350 of 686) with videos related to

Pageof 69
Sort By:
Diabetes Technology & Therapeutics|May 12, 2015
Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring SystemThomas A Peyser, Katherine Nakamura, David Price, et al.
Pharmacotherapy|February 24, 2023
Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases PharmacistsEric Wenzler, Mira Maximos, Tomefa E Asempa, et al.
Experimental and Clinical Endocrinology|January 1, 1994
In vivo-effect of intraadrenal nicotine and substance P application on rat adrenal medullary catecholamine secretionJ P Voigt, G Kaufmann, B Hirsch, et al.
Diabetes Technology & Therapeutics|November 13, 2023
The Role of a "Technology Navigator" in an Academic Diabetes Clinic: A Feasibility EvaluationPaige Edmiston, Sarah Lukhang Klippel, Jesica D Baran, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 25, 2025
Evaluation of cefazolin <3 g vs. 3 g treatment doses for cellulitis in patients who weigh ≥120 kg within a large, community health system via modified desirability of outcomes ranking (DOOR) methodologyKrista D Gens, Brandon R Gagnon, Kimberly C Claeys, et al.
Journal of Diabetes Science and Technology|March 17, 2018
In Response to Carter and Heinemann: Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply ChainMatthew P Petersen, Irl B Hirsch, Jay S Skyler, et al.
Journal of Diabetes Science and Technology|May 28, 2020
Smoking is Associated With Increased Risk of Not Achieving Glycemic Target, Increased Glycemic Variability, and Increased Risk of Hypoglycemia for People With Type 1 DiabetesMorten Hasselstrøm Jensen, Simon Lebech Cichosz, Irl B Hirsch, et al.
Current Drug Targets|February 10, 2009
Anti-CD30 human IL-2 fusion proteins display strong and specific cytotoxicity in vivoB Hirsch, J Brauer, M Fischdick, et al.
Joint Commission Journal on Quality and Safety|September 30, 2003
Using an Internet comanagement module to improve the quality of chronic disease careHarold I Goldberg, James D Ralston, Irl B Hirsch, et al.
Journal of Autism and Developmental Disorders|June 12, 2012
Eye-tracking, autonomic, and electrophysiological correlates of emotional face processing in adolescents with autism spectrum disorderJennifer B Wagner, Suzanna B Hirsch, Vanessa K Vogel-Farley, et al.
Pageof 69

Showing results (341-350 of 686) with videos related to

Sort By:
Pageof 69
Diabetes Technology & Therapeutics|May 12, 2015
Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring SystemThomas A Peyser, Katherine Nakamura, David Price, et al.
Pharmacotherapy|February 24, 2023
Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases PharmacistsEric Wenzler, Mira Maximos, Tomefa E Asempa, et al.
Experimental and Clinical Endocrinology|January 1, 1994
In vivo-effect of intraadrenal nicotine and substance P application on rat adrenal medullary catecholamine secretionJ P Voigt, G Kaufmann, B Hirsch, et al.
Diabetes Technology & Therapeutics|November 13, 2023
The Role of a "Technology Navigator" in an Academic Diabetes Clinic: A Feasibility EvaluationPaige Edmiston, Sarah Lukhang Klippel, Jesica D Baran, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|October 25, 2025
Evaluation of cefazolin <3 g vs. 3 g treatment doses for cellulitis in patients who weigh ≥120 kg within a large, community health system via modified desirability of outcomes ranking (DOOR) methodologyKrista D Gens, Brandon R Gagnon, Kimberly C Claeys, et al.
Journal of Diabetes Science and Technology|March 17, 2018
In Response to Carter and Heinemann: Insulin Concentration in Vials Randomly Purchased in Pharmacies in the United States: Considerable Loss in the Cold Supply ChainMatthew P Petersen, Irl B Hirsch, Jay S Skyler, et al.
Journal of Diabetes Science and Technology|May 28, 2020
Smoking is Associated With Increased Risk of Not Achieving Glycemic Target, Increased Glycemic Variability, and Increased Risk of Hypoglycemia for People With Type 1 DiabetesMorten Hasselstrøm Jensen, Simon Lebech Cichosz, Irl B Hirsch, et al.
Current Drug Targets|February 10, 2009
Anti-CD30 human IL-2 fusion proteins display strong and specific cytotoxicity in vivoB Hirsch, J Brauer, M Fischdick, et al.
Joint Commission Journal on Quality and Safety|September 30, 2003
Using an Internet comanagement module to improve the quality of chronic disease careHarold I Goldberg, James D Ralston, Irl B Hirsch, et al.
Journal of Autism and Developmental Disorders|June 12, 2012
Eye-tracking, autonomic, and electrophysiological correlates of emotional face processing in adolescents with autism spectrum disorderJennifer B Wagner, Suzanna B Hirsch, Vanessa K Vogel-Farley, et al.
Pageof 69